Vida Ventures Ii-A, LLC insider trades: Aktis Oncology (AKTS) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vida Ventures Ii-A, LLC reports to the SEC
Open-market buys and sales
2 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | AKTS | ↑ Buy | 835,000 | $18.00 | $15.0M | Indirect | Jan 12, 2026 (0d) |
| Sep 21, 2020 | DYN | ↑ Buy | 815,000 | $19.00 | $15.5M | Indirect | Sep 23, 2020 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other AKTS insiders
Open-market trades in the last 12 months
About Vida Ventures Ii-A, LLC's insider trades
Vida Ventures Ii-A, LLC is an insider at Aktis Oncology (AKTS). Since Sep 21, 2020, it has reported 2 open-market purchases worth $30.5M and no sales on SEC Form 4. In the last 12 months: 1 buy ($15.0M).
Its filings also include conversions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AKTS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.